normative
Finch sequences C. diff as its first proven indication
Finch chose C. difficile as its first indication because the company had experience serving those patients, and proving efficacy there creates a revenue floor that funds bigger bets in ulcerative colitis, Crohn's, and oncology.
normativepending
Speaker
Mark SmithEvidence Quote
“We saw C. diff as creating a floor value in the company where we know it works there. We know we can serve patients and have a reliable revenue stream.”
Created: 11/16/2026, 7:13:42 PM
Your notes
Loading notes...